⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30239899 | 1.00 | — | — | |
| SCHEMBL1647227 | 0.81 | — | — | |
| SCHEMBL30206002 | 0.81 | — | — | |
| SCHEMBL30239830 | 0.79 | — | — | |
| SCHEMBL1648413 | 0.79 | — | — | |
| SCHEMBL31750693 | 0.75 | — | — | |
| SCHEMBL15006461 | 0.75 | — | — | |
| SCHEMBL4153983 | 0.72 | — | — | |
| SCHEMBL28996579 | 0.70 | NOTUM (0.33) | — | |
| SCHEMBL13765824 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110903248-B | Synthesis method of 5-chloro-4-aminopyridazine | 郑州华赞医药科技有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-110903248-A | Synthesis method of 5-chloro-4-aminopyridazine | 郑州华赞医药科技有限公司 | 2020-03-24 | — | — | CN | disclosed |
| US-20080004270-A1 | 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors | ASTEX THERAPEUTICS LIMITED (UK) | 2008-01-03 | — | — | US | disclosed |
| EP-1781653-A1 | 3,4-DISUBSTITUTED PYRAZOLES AS CYCLIN DEPENDENT KINASES (CDK) OR AURORA KINASE OR GLYCOGEN SYNTHASE 3 (GSK-3) INHIBITORS | Astex Therapeutics Limited (GB) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006003440-A1 | 3,4-DISUBSTITUTED PYRAZOLES AS CYCLIN DEPENDENT KINASES (CDK) OR AURORA KINASE OR GLYCOGEN SYNTHASE 3 (GSK-3) INHIBITORS | ASTEX THERAPEUTICS LIMITED (GB) | 2006-01-12 | — | — | WO | disclosed |